全文获取类型
收费全文 | 29142篇 |
免费 | 3701篇 |
国内免费 | 29篇 |
出版年
2016年 | 251篇 |
2015年 | 320篇 |
2014年 | 406篇 |
2013年 | 670篇 |
2012年 | 647篇 |
2011年 | 697篇 |
2010年 | 490篇 |
2009年 | 407篇 |
2008年 | 596篇 |
2007年 | 648篇 |
2006年 | 615篇 |
2005年 | 623篇 |
2004年 | 622篇 |
2003年 | 638篇 |
2002年 | 647篇 |
2001年 | 1860篇 |
2000年 | 1832篇 |
1999年 | 1443篇 |
1998年 | 476篇 |
1997年 | 474篇 |
1996年 | 481篇 |
1995年 | 422篇 |
1994年 | 427篇 |
1993年 | 420篇 |
1992年 | 1070篇 |
1991年 | 1084篇 |
1990年 | 1066篇 |
1989年 | 1029篇 |
1988年 | 960篇 |
1987年 | 901篇 |
1986年 | 770篇 |
1985年 | 747篇 |
1984年 | 587篇 |
1983年 | 510篇 |
1982年 | 367篇 |
1981年 | 343篇 |
1980年 | 333篇 |
1979年 | 562篇 |
1978年 | 449篇 |
1977年 | 413篇 |
1976年 | 338篇 |
1975年 | 457篇 |
1974年 | 469篇 |
1973年 | 415篇 |
1972年 | 393篇 |
1971年 | 311篇 |
1970年 | 258篇 |
1969年 | 240篇 |
1968年 | 225篇 |
1967年 | 205篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
111.
M Plat J Fleischer T Herrmann U Plat A Lesche E M Grafe H Wolf U Reinhardt 《Folia haematologica (Leipzig, Germany : 1928)》1987,114(6):797-809
The total population affected with non-Hodgkin's lymphoma and treated by means of radiotherapy or combined radio-chemotherapy between 1960 and 1985 at the Medical Academy Dresden was analysed as to prognosis. 247 patients were classified according to the previous German scheme, 79 were subdivided on the basis of the recommendations laid down in the Kiel classification. The remission rates and survival curves achieved will stand out the comparison with international literature (remission rates of the low malignancy group amounted to 85.3 p.c. and those of the high malignancy group to 80.0 p.c.; the 5-years survival rates of the low malignancy group amounted to 61.9 p.c. and those of the high malignancy group to 41.7 p.c.). The influence of histology, clinical stage and involvement of organs is discussed on the basis of our results and informations obtained in literature. Our analysis confirms the high importance which must be attached to a common radiologic-internal outpatient-department for co-ordinating the diagnostic and therapeutical programme. 相似文献
112.
W E Berdel P Schick H Sedlmeier U Fink J Rastetter O Messerschmidt 《Radiation research》1983,94(1):166-170
Synthetic lysophospholipids represent a variety of analogs of the naturally occurring 2-lysophosphatidylcholine. Some of these compounds showed significant therapeutic effects on the survival of mice following radiation injury when administered after various doses of whole-body X irradiation. Such therapeutic effects were discernible even when the treatment was given 6 hr after irradiation, and both intravenous and oral application were effective. Intravenous application of 2 X 25 mg/kg lysophospholipid after whole-body X irradiation around the LD50 resulted in significantly higher numbers of surviving animals. The mode of action remains speculative. 相似文献
113.
114.
115.
116.
117.
118.
119.
L. Marklund M. Johansson U. Gustafsson L. Andersson A. K. Winterö M. Fredholm P. D. Thomsen 《Animal genetics》1993,24(5):333-338
Restriction fragment length polymorphisms (RFLPs) were described for the porcine loci for β-glucosidase (GBA) and the β-polypeptide 1 of the Na+, K+-transporting ATPase (ATP1B1). Linkage analyses using a three-generation pedigree provided evidence for the assignment of ATP1B1, GBA and two microsatellite loci (S0001 and S0067) to a previously described linkage group comprising the loci for blood group L (EAL) and an anonymous microsatellite (S0097). The linear order of the six markers was determined with confidence by multipoint analyses and the length of the linkage group was estimated at 88 CM. This linkage group was assigned to pig chromosome 4 on the basis of a previous physical localization of the ATP1B1 gene. In situ hybridization data for S0001 presented in this study were consistent with a localization on chromosome 4 and suggested a regional localization to 4pl2-pl3. The present study reveals conflicting data concerning the genetic localization of the K88 loci controlling the expression of the receptors for the E. coli pilus antigens. One group has reported data suggesting a loose linkage between K88 and EAL, now mapped to chromosome 4, whereas two other groups have found linkage between K88 and the transferrin locus (TF), mapped to chromosome 13 by in situ hybridization. 相似文献
120.
S Braig R M Wiedmann J Liebl M Singer R Kubisch L Schreiner B A Abhari E Wagner U Kazmaier S Fulda A M Vollmar 《Cell death & disease》2014,5(1):e1001
Tubulin-binding agents such as taxol, vincristine or vinblastine are well-established drugs in clinical treatment of metastatic cancer. However, because of their highly complex chemical structures, the synthesis and hence the supply issues are still quite challenging. Here we set on stage pretubulysin, a chemically accessible precursor of tubulysin that was identified as a potent microtubule-binding agent produced by myxobacteria. Although much simpler in chemical structure, pretubulysin abrogates proliferation and long-term survival as well as anchorage-independent growth, and also induces anoikis and apoptosis in invasive tumor cells equally potent to tubulysin. Moreover, pretubulysin posseses in vivo efficacy shown in a chicken chorioallantoic membrane (CAM) model with T24 bladder tumor cells, in a mouse xenograft model using MDA-MB-231 mammary cancer cells and finally in a model of lung metastasis induced by 4T1 mouse breast cancer cells. Pretubulysin induces cell death via the intrinsic apoptosis pathway by abrogating the expression of pivotal antiapoptotic proteins, namely Mcl-1 and Bcl-xL, and shows distinct chemosensitizing properties in combination with TRAIL in two- and three-dimensional cell culture models. Unraveling the underlying signaling pathways provides novel information: pretubulysin induces proteasomal degradation of Mcl-1 by activation of mitogen-activated protein kinase (especially JNK (c-Jun N-terminal kinase)) and phosphorylation of Mcl-1, which is then targeted by the SCFFbw7 E3 ubiquitin ligase complex for ubiquitination and degradation. In sum, we designate the microtubule-destabilizing compound pretubulysin as a highly promising novel agent for mono treatment and combinatory treatment of invasive cancer. 相似文献